HopeStage
Back to all studies
CompletedNCT00841269

Uridine for depression in adolescents with bipolarity

About this title

Oral Uridine for Treatment of Bipolar Depression in Adolescents

Read the official source — NCT00841269
Medication studyAges 13–18United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 13 years to 18 years.

Listed locations
Salt Lake CitySee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2009
Recruitment status
Completed
Enrollment listed in the registry
42
Sponsor
University of Utah
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 13 Years to 18 Years
Official registry ID
NCT00841269
Official title
Show the full official title

Oral Administration of Uridine for Treatment of Bipolar Depression in Adolescents: A Magnetic Resonance Spectroscopy Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Salt Lake City

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Utah, a university.

Did this study involve medication?

Yes. The study involved medication, including Uridine.

Who was this study for?

Listed age limits: 13 years to 18 years.

Want to explore more studies?

Explore studies